809 studies found for:    Open Studies | "Carcinoma, Bronchogenic"
Show Display Options
Rank Status Study
1 Unknown  Efficacy and Safety Study of Gefitinib in Squamous NSCLC Patients Who Failed First-Line Chemotherapy
Condition: Squamous Cell Carcinoma of Bronchus
Intervention: Drug: Gefitinib
2 Recruiting Feasibility of the Research for Mutation of K-ras and EGFR in CTCs From Metastatic Non Small Cells Bronchial Carcinomas
Condition: Non-small Cell Lung Cancer Metastatic
Intervention: Biological: CTC
3 Unknown  Study to Determine the Efficacy of Bendamustin in Patients With Recurrent Small Cell Lung Cancer (SCLC)
Condition: Recurrent Small Cell Lung Cancer
Intervention: Drug: Bendamustin/Ribomustin
4 Recruiting Phase I Trial of Afatinib (BIBW 2992) and Dasatinib in Non-small Cell Lung Cancer (NSCLC)
Conditions: Lung Cancer;   Non-small Cell Lung Cancer (NSCLC)
Interventions: Drug: Dasatinib - 1A;   Drug: Afatinib - 1A;   Drug: Dasatinib - 1B;   Drug: Afatinib - 1B
5 Recruiting Integrated Molecular Profiling in Advanced Cancers Trial
Conditions: Breast Cancer;   Non-small Cell Lung Cancer;   Colorectal Cancer;   Genitourinary Cancer;   Pancreatobiliary Gastrointestinal Cancer;   Upper Aerodigestive Tract Cancer;   Gynecological Cancers
Intervention:
6 Recruiting Collaborative Advanced Stage Tissue Lung Cancer (CASTLE) Network
Conditions: Non-small Cell Lung Cancer Metastatic;   Small Cell Lung Carcinoma
Intervention: Other: therapeutic interventions
7 Recruiting Study of Relationship Between UGT1A1 Gene Polymorphism and Toxicity and Efficacy of Irinotecan in Small Cell Lung Cancer
Condition: Small Cell Carcinoma of Lung
Intervention: Drug: Irinotecan
8 Recruiting Study of Everolimus, Pemetrexed, Carboplatin, and Bevacizumab to Treat Stage IV Lung Cancer
Condition: Non Small Cell Lung Cancer
Interventions: Drug: Everolimus;   Drug: Pemetrexed;   Drug: Carboplatin;   Drug: Bevacizumab
9 Recruiting PI3K Inhibitor BKM120, Carboplatin, and Pemetrexed Disodium in Treating Patients With Stage IV Non-Small Cell Lung Cancer
Conditions: Adenocarcinoma of the Lung;   Bronchoalveolar Cell Lung Cancer;   Large Cell Lung Cancer;   Recurrent Non-small Cell Lung Cancer;   Stage IV Non-small Cell Lung Cancer
Interventions: Drug: PI3K inhibitor BKM120;   Drug: pemetrexed disodium;   Drug: carboplatin;   Other: laboratory biomarker analysis;   Other: pharmacological study;   Procedure: quality-of-life assessment
10 Recruiting AUY922 for Advanced ALK-positive NSCLC
Condition: Non Small Cell Lung Cancer
Intervention: Drug: AUY922
11 Recruiting Icotinib as Adjuvant Therapy in Treating Non-small-cell Lung Cancer Patients With Positive EGFR Mutation
Condition: Non-small-cell Lung Cancer
Interventions: Drug: 1-year treatment with icotinib;   Drug: 2-year treatment with icotinib
12 Recruiting Proton Therapy for Stage I Non-Small Cell Lung Cancer (LU03)
Condition: Non-Small Cell Lung Cancer
Interventions: Radiation: Peripherally located lung tumor;   Radiation: Centrally located lung tumor
13 Recruiting Computed Tomography (CT) Perfusion Imaging of Lung Cancer
Condition: Carcinoma, Non Small Cell Lung
Intervention: Other: CT Perfusion
14 Recruiting Experience of Erlotinib in Patients With Advanced Non-Small Cell Lung Cancer
Condition: Non-small Cell Lung Cancer Metastatic
Intervention: Drug: Erlotinib
15 Recruiting A Study Of Crizotinib Versus Chemotherapy In Previously Untreated ALK Positive East Asian Non-Small Cell Lung Cancer Patients
Condition: NSCLC (Non-small Cell Lung Cancer)
Interventions: Drug: Crizotinib;   Drug: Pemetrexed/Cisplatin;   Drug: Pemetrexed/Carboplatin
16 Recruiting Icotinib Treat the Patient With Brain Metastasis Epidermal Growth Factor Receptor(EGFR) Mutant Non Small Cell Lung Cancer Comparing With Whole Brain Radiotherapy
Conditions: Brain Metastasis;   Non Small Cell Lung Cancer
Interventions: Radiation: whole brain radiation(WBI);   Drug: Icotinib
17 Recruiting TRAcking Non-small Cell Lung Cancer Evolution Through Therapy (Rx)
Condition: Non-small Cell Lung Cancer
Intervention: Other: No intervention
18 Recruiting Safety and Efficacy Study of Epitope Peptide To Treat HLA-A*02 Disease Controlled Advanced Non-small Cell Lung Cancer
Condition: Non-small Cell Lung Cancer
Intervention: Biological: HLA-A*0201restricted URLC10 peptides with adjuvant
19 Recruiting Detection of Genetic Markers of Lung Cancer
Condition: Non-small Cell Lung Cancer
Interventions: Procedure: Biopsy of the major carinal area;   Procedure: Biopsy of abnormal & suspicious areas of the bronchial tree;   Procedure: Evaluation of the tumor for DNA mutations;   Procedure: Bronchoalveolar Lavage (BAL) for cytokine analysis;   Procedure: Correlation of flow cytometric & RT PCR for TNM stage;   Procedure: Analysis of lymph nodes
20 Unknown  Non-Small Cell Lung Cancer and Quality of Life
Condition: Non Small Cell Lung Cancer
Intervention:

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years